⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6877303 | 0.78 | — | — | |
| SCHEMBL2317212 | 0.76 | — | — | |
| SCHEMBL4448340 | 0.75 | — | — | |
| SCHEMBL18092223 | 0.75 | — | — | |
| SCHEMBL4448341 | 0.75 | — | — | |
| SCHEMBL18092224 | 0.75 | — | — | |
| SCHEMBL16973817 | 0.75 | TAS1R3 (0.32) | — | |
| SCHEMBL5826956 | 0.72 | — | — | |
| SCHEMBL28346562 | 0.72 | MEN1 (0.34) | — | |
| SCHEMBL28411534 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180104353-A1 | LIGAND-TARGETED MOLECULES AND METHODS THEREOF | INVICTUS ONCOLOGY PVT. LTD. (IN) | 2018-04-19 | — | — | US | disclosed |
| US-6034069-A | 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity | ABBOTT LABORATORIES (US) | 2000-03-07 | — | — | US | disclosed |